Biochemical analysis of TEM-134, a new TEM-type extended-spectrum β-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 4, 2007, Pages 877-880

  Perilli, Mariagrazia ^a   Celenza, Giuseppe ^a   Fiore, Marianna ^a   Segatore, Bernardetta ^a   Pellegrini, Cristina ^a   Luzzaro, Francesco ^b   Rossolini, Gian Maria ^c   Amicosante, Gianfranco ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Antibiotic resistance; Class A; Enterobacteriaceae

Indexed keywords

AMPICILLIN; ARGININE; AZTREONAM; BETA LACTAMASE TEM 134; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; GLUTAMIC ACID; GLYCINE; HISTIDINE; LYSINE; NITROCEFIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BACTERIUM ISOLATE; BIOCHEMISTRY; CHROMATOFOCUSING; CITROBACTER KOSERI; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SUBSTRATE; GEL PERMEATION CHROMATOGRAPHY; GENETIC VARIABILITY; HYDROLYSIS; ION EXCHANGE CHROMATOGRAPHY; ITALY; MICHAELIS MENTEN KINETICS; MOLECULAR MODEL; NONHUMAN; STEADY STATE;

AMINO ACID SUBSTITUTION; BETA-LACTAMASES; BETA-LACTAMS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CITROBACTER KOSERI; CLONING, MOLECULAR; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HOSPITALS; ISOELECTRIC FOCUSING; ITALY; KINETICS; MODELS, MOLECULAR; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 34548808552     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm275     Document Type: Article

References (10)

1. Calbo E, Romani V, Xercavins M et al. Risk faclors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 780-3.
2. Sirot D, Sirot J, Labia A et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae, identification of CTX-1, a novel β-lactamase. J Antimicrob Chemother 1987; 20:323-34.
3. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
4. Nijssen S, Florijn A, Bonten MJM. β-Lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004; 24 585-91.
5. Perilli M, Dell'Amico E, Segatore B et al. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J Clin Microbiol 2002; 40: 611-4.
6. Luzzaro F, Mezzatesta M, Mugnaioli C et al. Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: Report of the second Italian nationwide survey. J Clin Microbiol 2006; 44: 1659-64.
7. Perilli M, Mugnaioli C, Luzzaro F et al. Novel TEM-type extended-spectrum β-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. Antimicrob Agents Chemother 2005; 49: 1564-6.
8. Raquet X, Lamotte-Brasseur J, Fonzé E et al. TEM β-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis. J Mol Biol 1994; 244: 625-39.
9. Cantu C, Palzkill T. The role of residue 238 of TEM-1. β-lactamase in the hydrolysis of extended-spectrum antibiotics. J Biol Chem 1998; 273: 26603-9.
10. Giakkoupi P, Tzelepi E, Tasslos PT et al. Detrimental effect of the combination of R164S with G238S in TEM-1 β-lactamase on the extended-spectrum activity, conferred by each single mutation. J Antimicrob Chemother 2000; 45: 101-4.